Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alunbrig (brigatinib)
Pharma
Pfizer sets up refund program for rare disease drug Panzyga
Pfizer has begun a warranty program for newly approved Panzyga, which treats the rare disorder chronic inflammatory demyelinating polyneuropathy.
Kevin Dunleavy
Aug 9, 2022 2:04pm
Pfizer gains its fourth FDA approval for an ALK-positive tumors
Jul 15, 2022 10:49am
Takeda, Merck, SK Biopharm and more—Fierce Pharma Asia
Nov 12, 2021 9:20am
Takeda offers value-based pricing for Alunbrig
Nov 8, 2021 9:00am
CanSino, Takeda, GSK, Samsung and more—FiercePharmaAsia
May 29, 2020 8:35am
Takeda's Alunbrig scores nod for earlier lung cancer use
May 26, 2020 11:37am
